GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » Ending Cash Position

Penumbra (MEX:PEN) Ending Cash Position : MXN7,693 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Penumbra Ending Cash Position?

Penumbra's Ending Cash Position for the quarter that ended in Mar. 2025 was MXN7,693 Mil.

Penumbra's quarterly Ending Cash Position increased from Sep. 2024 (MXN5,523 Mil) to Dec. 2024 (MXN6,766 Mil) and increased from Dec. 2024 (MXN6,766 Mil) to Mar. 2025 (MXN7,693 Mil).

Penumbra's annual Ending Cash Position increased from Dec. 2022 (MXN1,362 Mil) to Dec. 2023 (MXN2,843 Mil) and increased from Dec. 2023 (MXN2,843 Mil) to Dec. 2024 (MXN6,766 Mil).


Penumbra Ending Cash Position Historical Data

The historical data trend for Penumbra's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Ending Cash Position Chart

Penumbra Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,385.88 1,218.10 1,361.95 2,842.95 6,765.67

Penumbra Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,702.86 5,282.27 5,522.66 6,765.67 7,693.39

Penumbra Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Penumbra's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=3493.037+3272.635
=6,766

Penumbra's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6636.722+1056.666
=7,693


Penumbra Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Penumbra's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.